- Category
- Micro (2023-24)
- Udyam number
- UDYAM-AP-10-0018406

Bioluke Pharmaceuticals Private Limited
About Bioluke Pharmaceuticals Private Limited
Data last updated:
Bioluke Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC372395.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Paidi Rao Vasudeva (Managing Director) and Sateeshu Pydi.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No.611 Reliables Pride Anandnagar Opp. Heera Panna Mall Jogeshwari (W), Mumbai, Maharashtra, India – 400102.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.8 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹16.52 Lakh (net margin -38.6%) and EBITDA of -₹8.81 Lakh (EBITDA margin -20.6%). Revenue has grown at a compounded annual rate (CAGR) of 154% over three years.
Bioluke Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0018406).
Company details
Recognitions & Rankings of Bioluke Pharmaceuticals
Contact details
Bioluke Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressUnit No.611 Reliables Pride Anandnagar Opp. Heera Panna Mall Jogeshwari (W), Mumbai, Maharashtra, India – 400102
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bioluke Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Bioluke Pharmaceuticals Private Limited, buy the company report.
Financials of Bioluke Pharmaceuticals Private Limited
FY 2025 filings availableBioluke Pharmaceuticals Private Limited reported revenue of ₹42.8 Lakh (down 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 27% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 154%. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹8.81 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹16.52 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -20.6% | |||
| Net Profit Margin | -38.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bioluke Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bioluke Pharmaceuticals Private Limited
Bioluke Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sateeshu Pydi | Director | 29 Nov 2021 | 4 Years 11 Months | Current |
| Paidi Rao Vasudeva | Managing Director | 29 Nov 2021 | 4 Years 11 Months | Current |
| Naveen Chakravarthy Sattaru | Director | 31 Oct 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Bioluke Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioluke Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bioluke Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bioluke Pharmaceuticals Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Naveen Chakravarthy Sattaru was appointed as Director on 31 Oct 2025.
Frequently asked questions
Bioluke Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 November 2021 (5+ years old) and is registered under CIN U24290MH2021PTC372395.
Bioluke Pharmaceuticals has 3 current directors:
- Paidi Rao Vasudeva - Managing Director
- Sateeshu Pydi - Director
- Naveen Chakravarthy Sattaru - Director
The latest financial statements of Bioluke Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Bioluke Pharmaceuticals is U24290MH2021PTC372395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioluke Pharmaceuticals was incorporated on 29 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Naveen Chakravarthy Sattaru was appointed as Director on 31 Oct 2025. Mahesh Chandra Suvvari ceased to be Director on 25 Jan 2022. Suvvari Rama Krishna ceased to be Director on 25 Jan 2022. Bioluke Pharmaceuticals has 5 board changes on record in total.
Yes, Bioluke Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-10-0018406).
The registered office of Bioluke Pharmaceuticals is at Unit No.611 Reliables Pride Anandnagar Opp. Heera Panna Mall Jogeshwari W, Mumbai, Maharashtra, India – 400102.
Bioluke Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Bioluke Pharmaceuticals can be reached at its registered office: Unit No.611 Reliables Pride Anandnagar Opp. Heera Panna Mall Jogeshwari W, Mumbai, Maharashtra, India – 400102.

